Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma

CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. EVIDENCE ACQUISITION: At present, radiofrequency ablation (RFA) is accepted as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Himoto, Takashi, Kurokohchi, Kazutaka, Watanabe, Seishiro, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496873/
https://www.ncbi.nlm.nih.gov/pubmed/23162600
http://dx.doi.org/10.5812/hepatmon.5945
_version_ 1782249682184962048
author Himoto, Takashi
Kurokohchi, Kazutaka
Watanabe, Seishiro
Masaki, Tsutomu
author_facet Himoto, Takashi
Kurokohchi, Kazutaka
Watanabe, Seishiro
Masaki, Tsutomu
author_sort Himoto, Takashi
collection PubMed
description CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. EVIDENCE ACQUISITION: At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments. RESULTS: New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects. CONCLUSIONS: This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.
format Online
Article
Text
id pubmed-3496873
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-34968732012-11-16 Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma Himoto, Takashi Kurokohchi, Kazutaka Watanabe, Seishiro Masaki, Tsutomu Hepat Mon Review Article CONTEXTS: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. EVIDENCE ACQUISITION: At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments. RESULTS: New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects. CONCLUSIONS: This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology. Kowsar 2012-10-10 /pmc/articles/PMC3496873/ /pubmed/23162600 http://dx.doi.org/10.5812/hepatmon.5945 Text en Copyright © 2012 Kowsar Corp. http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Himoto, Takashi
Kurokohchi, Kazutaka
Watanabe, Seishiro
Masaki, Tsutomu
Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
title Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
title_full Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
title_fullStr Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
title_full_unstemmed Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
title_short Recent Advances in Radiofrequency Ablation for the Management of Hepatocellular Carcinoma
title_sort recent advances in radiofrequency ablation for the management of hepatocellular carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496873/
https://www.ncbi.nlm.nih.gov/pubmed/23162600
http://dx.doi.org/10.5812/hepatmon.5945
work_keys_str_mv AT himototakashi recentadvancesinradiofrequencyablationforthemanagementofhepatocellularcarcinoma
AT kurokohchikazutaka recentadvancesinradiofrequencyablationforthemanagementofhepatocellularcarcinoma
AT watanabeseishiro recentadvancesinradiofrequencyablationforthemanagementofhepatocellularcarcinoma
AT masakitsutomu recentadvancesinradiofrequencyablationforthemanagementofhepatocellularcarcinoma

Ejemplares similares